CSTM director Deslarzes purchases $41,247 worth of shares in open-market transaction
Director Jean-Christophe Deslarzes bought shares at a price near the company's current trading level, adding to his holdings at a moment when the stock has recovered sharply over recent months from much lower levels. Constellium is a profitable company with solid fundamentals—growing revenue and positive earnings—trading at a reasonable valuation multiple. This purchase by a sitting director signals conviction in the company's near-term direction, particularly notable because it comes after the stock has already staged a significant recovery, suggesting Deslarzes sees further upside rather than attempting to catch a bottom. The modest size of the purchase (a small fraction of his holdings) is typical for routine board-member activity, but the timing during a strong uptrend rather than a pullback adds credibility to the signal.
Director Deslarzes buys 1,665 (1.7K shares) of CSTM at $24.77; 3 other insiders bought within 14 days as stock rises 39.4% YTD.
Director Jean-Christophe Deslarzes purchased 1,665 shares on 2026-03-02, increasing his holdings to 40,700 shares. This transaction is notable because it occurs as part of a cluster pattern: 3 other insiders also bought within the past 14 days. The stock has appreciated significantly over the medium term (+39.4% over the past 90 days) while trading near its 52-week high, and the company exhibits solid fundamentals with $2.2B in quarterly revenue and 15.2% annual revenue growth. The convergence of multiple insider purchases during a period of strong recent price appreciation warrants investor attention to understand whether insiders view current levels as attractive or if there are other strategic considerations driving the coordinated activity.
